LEADER 01771nam  2200505I  450 
001 9910707117203321
005 20160601153942.0
035   $a(CKB)5470000002462329
035   $a(OCoLC)950980485
035   $a(EXLCZ)995470000002462329
100   $a20160601j201603    ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPharmaceuticals exposed to the space environment: problems and prospects /$fDonald A. Jaworske and Jerry G. Myers
210  1$aCleveland, Ohio :$cNational Aeronautics and Space Administration, Glenn Research Center,$dMarch 2016.
215   $a1 online resource (7 pages) $ccolor illustrations
225 1 $aNASA/TM ;$v2016-218949
300   $aTitle from title screen (viewed on June 1, 2016).
300   $a"March 2016."
320   $aIncludes bibliographical references (page 7).
517   $aPharmaceuticals exposed to the space environment
606   $aAerospace medicine$2nasat
606   $aCryogenic temperature$2nasat
606   $aPharmacology$2nasat
606   $aRadiation chemistry$2nasat
606   $aSpace storage$2nasat
606   $aWeibull density functions$2nasat
615  7$aAerospace medicine.
615  7$aCryogenic temperature.
615  7$aPharmacology.
615  7$aRadiation chemistry.
615  7$aSpace storage.
615  7$aWeibull density functions.
700   $aJaworske$b Donald A.$01394112
702   $aMyers$b Jerry G.
712 02$aNASA Glenn Research Center,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910707117203321
996   $aPharmaceuticals exposed to the space environment: problems and prospects$93483140
997   $aUNINA